NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

Active Not RecruitingN/A

Sponsor: Sanofi

Conditions: Atopic Dermatitis

Interventions: Dupilumab

Countries: Spain

This is a multicentre, prospective, non-interventional study that aims to describe the treatment patterns of in Atopic dermatitis (AD) patients aged 6 months to 11 years old in Spain: patients' characteristics, disease characteristics, prior treatments for and treatment prescription modalities. As well as to document the real-world effectiveness and safety of dupilumab during the two years of follow up. No diagnostic or therapeutic intervention outside of routine clinical practice will be applied.

Eligibility overview

Sex: ALL

Age: 6 Months to 11 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Male or female aged 6 months to 11 years old at baseline.
* Patients with severe Atopic dermatitis (AD) according to the investigator's assessment.
* Patients initiating dupilumab (in those patients initiated retrospectively 2 months before the start of the study, the baseline information must be correctly filled out in the medical records).
* Signed informed consent by the parent/legally acceptable representative and assent by the patient appropriate to the patient's age.

Exclusion Criteria:

* Patients who are participating in an interventional clinical trial that modifies patient care.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Locations (15)

Santiago de Compostela, A Coruña [La Coruña], Spain
Esplugues de Llobregat, Barcelona [Barcelona], Spain
Oviedo, Principality of Asturias, Spain
Seville, Sevilla, Spain
Alicante, Spain
Barcelona, Spain
Madrid, Spain
Madrid, Spain
Madrid, Spain
Madrid, Spain
Málaga, Spain
Palma, Spain
San Cristóbal de La Laguna, Spain
Valencia, Spain
Zaragoza, Spain